Still, the presence of a somatic mutation has not been included as a diagnostic criterion for MDS (with the exception of SF3B1 mutations for MDS with ring sideroblasts [14]), which may in part be due to the broad overlap of the mutational spectrum between MDS and CHIP [15]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.